← Open Payments lookup

ROBIN CASSIDY: Open Payments

NPI 1215968789 · APEX, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,271 in 58 payments from 14 companies in 2025. Trend: 2023 $993 · 2024 $939 · 2025 $1,271

Food & beverage: $1,271
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.10$262
ABBVIE INC.10$229
Lundbeck LLC9$166
Vanda Pharmaceuticals Inc.7$148
Neurocrine BioSciences, Inc.4$99
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$84
Otsuka America Pharmaceutical, Inc.3$65
E.R. Squibb & Sons, L.L.C.3$52
Takeda Pharmaceuticals U.S.A., Inc.2$44
Axsome Therapeutics, Inc.2$39

Products named: AUSTEDO XR, REXULTI, VRAYLAR, HETLIOZ, INGREZZA, CAPLYTA, COBENFY, TRINTELLIX.

Industry payments across NC — which companies pay providers there.